Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Sch 21420

Known as: Sch-21420 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1994
1994
The in vitro antimicrobial susceptibilities of 42 isolates of rapidly growing mycobacteria (Mycobacterium fortuitum, M. chelonae… Expand
Is this relevant?
1993
1993
The in vitro activities of various quinolones, two new aminoglycosides, a new cephamycin analog (cefmetazole) and a new… Expand
Is this relevant?
1990
1990
Following the use of amikacin as the principal aminoglycoside at a Denver hospital, amikacin resistance appeared first in… Expand
Is this relevant?
1980
1980
Disk susceptibility tests with two structurally related aminoglycosides (amikacin and Sch 21420) were evaluated. Tests with 10… Expand
  • figure 1
  • figure 2
  • table 2
Is this relevant?
1980
1980
Sch 21420 is a new aminoglycoside synthesized from gentamicin B. Susceptibility tests with Sch 21420, amikacin, gentamicin… Expand
Is this relevant?
1979
1979
The nephrotoxic potentials of the new aminoglycoside SCH 21420 and amikacin were compared in a rat model. Groups of rats received… Expand
  • figure 1
  • table 1
Is this relevant?
1978
1978
In vitro tests were performed with Sch 21420 and Sch 22591 to determine (i) their activity in comparison to six other… Expand
Is this relevant?
1978
1978
The minimal inhibitory concentration of Sch-21420 closely paralleled amikacin for 125 strains of aerobic gram-negative bacilli… Expand
Is this relevant?
1978
1978
The syntheses of 1-N-(S-4-amino-2-hydroxybutyryl)-gentamicin B and 1-N-(S-3-amino-2-hydroxypropionyl)-gentamicin B, designated… Expand
  • table 1
  • table 3
  • table 4
Is this relevant?
1978
1978
Sch 21420, the 1-N-HAPA derivative of gentamicin B, has been compared to gentamicin, tobramycin and amikacin in a variety of in… Expand
Is this relevant?